Overview
- Editors:
-
-
Galen S. Wagner
-
Duke University Medical Center, Durham, USA
Access this book
Other ways to access
Table of contents (22 chapters)
-
Front Matter
Pages i-xiii
-
-
Methods for Determining Infarct Size
-
-
- Ronald H. Selvester, Miguel E. Sanmarco, Joseph C. Solomon, Galen S. Wagner
Pages 23-50
-
- Morton F. Arnsdorf, Eric K. Louie
Pages 51-106
-
-
- Frederick R. Cobb, Charles R. Roe
Pages 143-158
-
- William J. Rogers, Huey G. McDaniel, John A. Mantle, Silvio E. Papapietro, Richard O. Russell Jr., Charles E. Rackley
Pages 159-172
-
-
- Frans J. Th. Wackers, Harvey J. Berger, Barry L. Zaret
Pages 199-233
-
- Richard S. Stack, Joseph Kisslo
Pages 235-260
-
- J. William Whitaker, Erik L. Ritman
Pages 261-276
-
- Frederick R. Cobb, Robert H. Murdock Jr., Kenneth G. Morris
Pages 277-294
-
- Robert D. Okada, Charles A. Boucher, Gerald M. Pohost
Pages 295-324
-
- Melvin L. Marcus, Raymundo T. Go, James C. Ehrhardt
Pages 325-346
-
- Raymond E. Ideker, Donald B. Hackel, Eric C. McClees
Pages 347-371
-
-
Interventions for Limiting Infarct Size
-
Front Matter
Pages 385-385
-
About this book
Patients currently experiencing acute myocardial infarcts are the beneficiaries of information gathered during the 80 years since this clinical phenomenon was described and the 20 years since treatment in coronary care units was introduced. Physicians have gained the ability to minimize inhospital mortality from rhythm disturbances and have gained insight into the importance of optimizing both left ventricular fIlling pressure and outflow resistance in the management of myocar dial failure. Understanding of the pathophysiology of acute myocardial infarcts has matured sufficiently so that now it is possible to consider whether an infarct must evolve to a predetermined size or whether the size could be limited by implementing one or more clinically feasible strategies. Concurrently, it has become evident that patients with acute infarcts are not as 'fragile' as previously supposed, and that they may undergo procedures such as coronary angiography and coronary bypass surgery with acceptable risks. Clinical trials are currently in progress to assess the possible benefit of various interventions for limiting myocardial infarct size. The outcome of these studies may be used to formulate strategies for clinical care of future patients. If the results are positive, community hospitals may undergo changes even more exten sive than those required when they established coronary care units. If the inter ventions are not proven to provide significant advantages over the course of nature, the current concepts of coronary care may be retained. However, such conclusions will be only as valid as the techniques used to measure infarct size.
Editors and Affiliations
-
Duke University Medical Center, Durham, USA
Galen S. Wagner
